A
CASC

Abingworth’s Cascadian Therapeutics, Inc. CASC Stock Holding History

Abingworth’s Portfolio CASC Stock Details CASC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-925,000
Closed -$3.42M – 17
2017
Q4 		$3.42M Hold
925,000
– – 2.48% 9
2017
Q3 		$3.78M Hold
925,000
– – 2.62% 7
2017
Q2 		$3.43M Hold
925,000
– – 2.73% 5
2017
Q1 		$3.83M Buy
+925,000
New +$3.83M 2.85% 5